https://www.selleckchem.com/pr....oducts/santacruzamat
97 ± 1.92 versus 2.27 ± 2.02 ( -value 0.124) the decrease in artificial tear substitute use was 3.90 ± 2.22 versus 3.63 ± 1.92 ( -value 0.616), increase in Schirmer I values were 4.10 ± 4.21 and 4.26 ± 2.00 ( -value 0.59 in eyes treated with tacrolimus and cyclosporine respectively. Neither of them affected meibum quality or expressibility scores. Both tacrolimus and cyclosporine significantly improved patient symptoms, frequency of artificial tears use and ocular surface staining compared to placebo-controlled eyes.
Like
Comment
Share
